Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 83.62M
March 31, 2026 84.45M
December 31, 2025 86.63M
September 30, 2025 88.50M
June 30, 2025 83.20M
March 31, 2025 75.04M
December 31, 2024 41.26M
September 30, 2024 40.52M
June 30, 2024 40.32M
March 31, 2024 50.59M
December 31, 2023 40.62M
September 30, 2023 48.39M
June 30, 2023 49.09M
March 31, 2023 45.62M
December 31, 2022 26.27M
September 30, 2022 26.35M
June 30, 2022 26.42M
March 31, 2022 26.49M
December 31, 2021 2.513M
September 30, 2021 2.686M
June 30, 2021 22.94M
March 31, 2021 22.45M
December 31, 2020 21.98M
September 30, 2020 59.62M
June 30, 2020 59.09M
Date Value
March 31, 2020 58.57M
December 31, 2019 107.11M
September 30, 2019 139.70M
June 30, 2019 137.53M
March 31, 2019 125.78M
December 31, 2018 120.45M
September 30, 2018 25.06M
June 30, 2018 24.90M
March 31, 2018 14.91M
December 31, 2017 14.83M
September 30, 2017 2.335M
June 30, 2017 2.293M
March 31, 2017 2.249M
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 59.55M
Dianthus Therapeutics, Inc. 0.913M
Alnylam Pharmaceuticals, Inc. 2.942B
Anika Therapeutics, Inc. 23.32M
Savara, Inc. 30.11M